JG
GBT

Joel Greenblatt’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Joel Greenblatt’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,953
Closed -$261K – 1257
2019
Q2 		$261K Buy
+4,953
New +$285K ﹤0.01% 991

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Joel Greenblatt's GBT Position: Q3 2019 in Review

Joel Greenblatt sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2019, closing a stake of 4,953 shares — an estimated $261K sold.

Joel Greenblatt first reported a position in GBT in Q2 2019 and held it in 1 quarter. The position peaked at $261K in Q2 2019. 208 funds tracked by Wall St. Rank hold GBT as of Q3 2019.

  • Joel Greenblatt reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Joel Greenblatt sold 4,953 Global Blood Therapeutics, Inc. shares in Q3 2019, an estimated $261K.
  • Joel Greenblatt first reported a position in Global Blood Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
  • Joel Greenblatt's Global Blood Therapeutics, Inc. position peaked at $261K in Q2 2019.
  • 208 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2019.

Based on Gotham Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.